3rd Annual Advances in Immuno-Oncology Congress
July 24, 2018 - London UKOxford Global Conferences
a.fernandez@oxfordglobal.co.uk
Phone:44 (0)1865 250985
Following on from its huge success in 2017, Oxford Global are proud to present their 3rd Annual Advances in Immuno-Oncology Congress, 24-25 May, London, UK. This event will host over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. The worlds most leading authorities will give over 50 presentations across 6 interactive streams, including; • Discovery of Immuno-Oncology Therapies • Translational Immuno-Oncology • Genomics in Cancer Immunotherapy and Precision Medicine • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology • Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials • Microbiome in Immuno-Oncology Free Pre-Congress Live Webinars Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd. Register Here: http://bit.ly/2BeBVBc Personalised Medicine and Immuno-Oncology Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody. Register Here: http://bit.ly/2AZUJzU For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk or click here: http://bit.ly/2oJlVB7 Alternatively visit our website http://bit.ly/2kiJtbg